Botulinum Toxin for Neuropathic Pain: A Review of the Literature - Wikidata - wikimedia - TriplyDB

Botulinum Toxin for Neuropathic Pain: A Review of the Literature

Botulinum Toxin for Neuropathic Pain: A Review of the Literature

http://www.wikidata.org/entity/Q26796604

about

Botulinum Toxin A for Bladder Pain Syndrome/Interstitial Cystitis Botulinum Toxin A and Lower Urinary Tract Dysfunction: Pathophysiology and Mechanisms of Action Central antinociceptive activity of peripherally applied botulinum toxin type A in lab rat model of trigeminal neuralgia.Botulinum neurotoxin type A for the treatment of pain: not just in migraine and trigeminal neuralgia.Botulinum Toxin: Pharmacology and Therapeutic Roles in Pain States.Intra-articular injections of botulinum toxin a for refractory joint pain: a systematic review and meta-analysis.Bacterial Signaling to the Nervous System through Toxins and Metabolites.[Botulinum toxin A injections in neuropathic pain : A post-hoc subgroup analysis of patients with peripheral nerve injury].Botulinum Neurotoxin Type-A for the Treatment of Atypical Odontalgia.[Use of intracutaneous or subcutaneous botulinum toxin for postherpetic neuralgia].Impact of Botox-A SNAP-25 protein expression and the mechanism of inhibitory neurotransmitter imbalance in chronic sciatic nerve pain rat model.The Role and Treatment Implications of Peripheral and Central Processing of Pain, Pruritus, and Nausea in Heightened Somatic Awareness: A Review.Post-herpetic neuralgia - a review of current management and future directions.Botulinum Toxin Type A Injection for Neuropathic Pain in a Patient With a Brain Tumor: A Case Report.Analgesic Effects of Botulinum Toxin in Children with CP.Engineering of Botulinum Neurotoxins for Biomedical Applications.Clinical analysis of 86 botulism cases caused by cosmetic injection of botulinum toxin (BoNT)

P2860

Q26744717-C58FBC2D-DADB-4E3E-8E85-5769EB65D1EB Q26750535-D0609F00-6D00-40C5-A1B1-1A934A90E361 Q36788893-28C0797D-FA12-428A-A9EC-3DE5FF335DB5 Q37714487-8F3BD265-74B6-4382-B171-2B77042E7E91 Q38734744-3791EDD1-D2EB-491F-8AA1-1563A4BF8A92 Q38812041-A4F53B34-B4E3-4537-A459-FC34072197BE Q39075039-EAFCB327-F583-4DCA-B5C4-982D22072337 Q39153537-1716BF50-9B46-4C22-A46D-6E3F33E00CBC Q39174071-866BC28D-DFE7-4E11-8C5E-6B628419243B Q40421111-92E602F5-3791-40AE-BFC2-41CB18D18063 Q42235421-36258BFC-D9B6-40F7-8789-F36507E409B8 Q42360911-E7F22C4E-BFEC-4A8E-80E7-F4B238BCB53C Q47242634-467412B0-CCBA-4172-824C-FEAA12B84771 Q47848932-6165B590-D4BD-4E3E-87D8-51EE4A21A3E0 Q52578395-9CE9224F-2693-4098-8A94-90A0F72B9368 Q55460011-DD5D68B6-B41D-46E4-BCB2-E4655419505C Q58706360-E6ADC43E-0550-45D7-9DA1-A824399077FE

P2860

Botulinum Toxin for Neuropathic Pain: A Review of the Literature

http://www.wikidata.org/entity/Q26796604

description

2015 nî lūn-bûn

@nan

2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Botulinum Toxin for Neuropathic Pain: A Review of the Literature

@ast

Botulinum Toxin for Neuropathic Pain: A Review of the Literature

@en

Botulinum Toxin for Neuropathic Pain: A Review of the Literature

@nl

type

label

Botulinum Toxin for Neuropathic Pain: A Review of the Literature

@ast

Botulinum Toxin for Neuropathic Pain: A Review of the Literature

@en

Botulinum Toxin for Neuropathic Pain: A Review of the Literature

@nl

prefLabel

Botulinum Toxin for Neuropathic Pain: A Review of the Literature

@ast

Botulinum Toxin for Neuropathic Pain: A Review of the Literature

@en

Botulinum Toxin for Neuropathic Pain: A Review of the Literature

@nl

P1433

Q26796604-000F837F-BBBE-45E5-A7A7-EFA204FD721D

P1476

Q26796604-4FCD7276-C876-454E-A721-12F7539B3612

P2093

Q26796604-303A8DAF-C9AA-4206-B2AA-AE095B1C42F6

Q26796604-322F6C29-EF04-42F1-981C-6CE07B84D5CD

P275

Q26796604-8099AE50-258D-4310-A715-AC754EB75E4F

P2860

Q26796604-038540A3-88A1-48D9-B571-0265ECFFBFA0

Q26796604-041EFDF8-03FB-409A-AE16-6C416419C97C

Q26796604-09A88432-F678-4FD7-8D88-3F4CD16B6D1B

Q26796604-0A785C97-614A-4265-911F-EF73848A0604

Q26796604-0ECBB849-0282-4506-9C26-194173CB6DBF

Q26796604-1412F89B-035F-480C-977C-99409D192A63

Q26796604-177EAC06-1874-4A90-892F-77B0C1D753A1

Q26796604-1837E4E4-3A56-40F8-8B46-69797124777A

Q26796604-217B581F-A45A-4FEB-B6A7-528B94B7CEF0

Q26796604-2560F4A7-EDCE-424B-B428-C27A7533B169

P304

Q26796604-0C640E79-3FE2-44C1-AD86-68115CD56B1E

P31

Q26796604-8D30DEAF-CDD5-415C-9E6A-88B419D9BEE5

Q26796604-D3834E15-2C61-4E23-BCF3-74F78E2BA0DE

P3181

Q26796604-A5CFE8CE-913C-4156-8A22-4167A4F5776F

P356

Q26796604-A5C04DED-DD6F-4EAD-AA51-723D3F75913F

P407

Q26796604-09A68338-D141-45F6-9F81-6025B3FE6801

P433

Q26796604-8273CBCE-30B0-483B-AE00-CF61EF8EABCC

P478

Q26796604-0CC7BC67-FAD4-47DF-B0A4-16896CC70814

P5008

Q26796604-160B630A-12D8-4B5B-8439-A68E5FF7C648

P577

Q26796604-15C87152-582F-457A-BE16-437DFA73DB99

Q26796604-C7844E1B-AEA1-4E79-A45D-05962F48D391

P5875

Q26796604-3312DC53-94B7-4549-84C3-12C0B717C5E4

P698

Q26796604-89407861-6A5F-4A30-BEC5-CB150B50AADE

P921

Q26796604-53E48358-7EE9-4DBB-BC56-11CF0DAC7B7F

Q26796604-70C48FD5-CE85-48BC-AC3A-2DBDC0F187DC

Q26796604-BFD5CF59-883D-4538-8AE7-25F81C39DEF9

P932

Q26796604-C77716AF-070F-41D7-BE66-CF25B2A9D914

P3181

P356

P1433

P1476

Botulinum Toxin for Neuropathic Pain: A Review of the Literature

@en

P2093

Hyun-Mi Oh

http://www.w3.org/2001/XMLSchema#string

Myung Eun Chung

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy

Regulated exocytosis contributes to protein kinase C potentiation of vanilloid receptor activity

Botulinum toxin type A reduces capsaicin-evoked pain and neurogenic vasodilatation in human skin.

High-threshold mechanosensitive ion channels blocked by a novel conopeptide mediate pressure-evoked pain

Tetanus and botulinum neurotoxins: mechanism of action and therapeutic uses.

Botulinum toxin in spasmodic torticollis.

OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program.

Botulinum toxin-A treatment reduces human mechanical pain sensitivity and mechanotransduction.

OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.

Central action of peripherally applied botulinum toxin type A on pain and dural protein extravasation in rat model of trigeminal neuropathy.

P304

3127-54

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2164057

http://www.w3.org/2001/XMLSchema#string

P356

10.3390/TOXINS7083127

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2015-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2015-08-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281138024

http://www.w3.org/2001/XMLSchema#string

P698

26287242

http://www.w3.org/2001/XMLSchema#string

P921

neuropathic pain

bacterial protein

P932

4549742

http://www.w3.org/2001/XMLSchema#string